动脉粥样硬化相关LncRNA的研究
The Research on Long Noncoding RNA Related to Atherosclerosis
摘要: 目的:筛选并验证新的调控动脉粥样硬化的差异lncRNA,为该类疾病的治疗和预后提供新的思路。方法:1) 100 ug/ml ox-LDL刺激人主动脉血管平滑肌细胞24 h作为实验组,正常人主动脉血管平滑肌细胞作为对照组,质检合格后,Trizol法提取总RNA,进行高通量测序,筛选符合标准的表达上调的差异lncRNA。qPCR验证差异lncRNA。2) shRNA慢病毒载体感染HAVSMC,检测目的基因敲减后表达量。3) 将人主动脉血管平滑肌细胞分为正常组、ox-LDL处理组、ox-LDL + shBOLA3-AS1、ox-LDL + shPOC1B-AS1、ox-LDL + shGRXCR1-4,采用CCK8和Transwell法检测各组HAVSMC的增殖迁移能力,ELISA法测定胆固醇水平。结果:1) 初步筛选三种显著表达上调的lncRNA:BOLA3-AS1、POC1B-AS1、GRXCR1-4。2) 各敲减组中目标lncRNA的表达水平均显著降低(P < 0.05)。3) 下调三种差异基因表达后,与ox-LDL处理组相比,其增殖活性,迁移能力及胆固醇水平均显著降低(P < 0.01)。结论:LncRNABOLA3-AS1、POC1B-AS1、GRXCR1-4显著表达上调并参与调控动脉粥样硬化的进程。
Abstract: Objective: Filter and verify new regulatory atherosclerosis LncRNA to provide new ideas for the treatment and prognosis of such diseases. Methods: 1) 100 ug/ml ox-LDL stimulates human aortic blood vessel smooth muscle cells for 24 h as the experimental group, and normal people’s aortic blood vessel smooth muscle cells are used as a control group. After qualified quality inspection, to-tal RNA was extracted by Trizol method for high-throughput sequencing to screen the differential lncRNA with upregulated expression that met the criteria. Differential lncRNA was verified by qPCR. 2) HAVSMC was infected with shRNA lentiviral vector, and the expression of target gene was de-tected after knockdown. 3) Select the most effective interference targets, divide human aortic blood vessel smooth muscle cells into normal group, ox-LDL treatment group, ox-LDL + shBOLA3-AS1, ox-LDL + shPOC1B-AS1, ox-LDL + shGRXCR1-4. The CCK8 and Transwell Method were used to detect the proliferation migration capabilities of each group of HAVSMC, and the ELISA method was used to determine cholesterol levels. Results: 1) Preliminary screening of three significant expression of LncRNA: BOLA3-AS1, POC1B-AS1, GRXCR1-4. 2) The expression level of the target LncRNA in each knocking group was significantly reduced (P < 0.05). 3) After the three different genes are lowered, compared with the ox-LDL processing group, its proliferation activity, migration capabilities and cholesterol levels are significantly reduced (P < 0.01). Conclusion: LncRNA BOLA3-AS1, POC1B-AS1, GRXCR1-4 significantly increased and participated in the process of regulating atherosclerosis.
文章引用:汪志伟, 丁洋, 万圣云. 动脉粥样硬化相关LncRNA的研究[J]. 临床医学进展, 2022, 12(11): 10374-10382. https://doi.org/10.12677/ACM.2022.12111495

参考文献

[1] 赵小芳, 郑华波, 刘承云. SIRT6在动脉粥样硬化中的研究进展[J]. 中国老年学杂志, 2021, 41(11): 2436-2439.
[2] Holdt, L.M., Kohlmaier, A. and Teupser, D. (2019) Long Noncoding RNAs of the Arterial Wall as Therapeutic Agents and Targets in Atherosclerosis. Thrombosis and Haemostasis, 119, 1222-1236. [Google Scholar] [CrossRef] [PubMed]
[3] 李飞飞, 侯欣, 欧敬民, 等. 长链非编码RRS1-AS1/miR-142-3p/TRIM24分子轴对脂多糖诱导的血管内皮细胞凋亡的影响[J]. 中国心血管病研究, 2021, 19(8): 752-756.
[4] Sun, H., Jiang, Q., Sheng, L. and Cui, K. (2020) Downregulation of lncRNA H19 Alleviates Ath-erosclerosis through Inducing the Apoptosis of Vascular Smooth Muscle Cells. Molecular Medicine Reports, 22, 3095-3102. [Google Scholar] [CrossRef] [PubMed]
[5] Reuter, J.A., Spacek, D.V. and Snyder, M.P. (2015) High-Throughput Sequencing Technologies. Molecular Cell, 58, 586-597. [Google Scholar] [CrossRef] [PubMed]
[6] Charlebois, R.L., Sathiamoorthy, S., Logvinoff, C., Gisonni-Lex, L., Mallet, L. and Ng, S.H.S. (2020) Sensitivity and Breadth of Detection of High-Throughput Sequencing for Adventi-tious Virus Detection. NPJ Vaccines, 5, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[7] Li, C., Liu, M., An, Y., et al. (2021) Risk Assessment of Type 2 Diabetes in Northern China Based on the Logistic Regression Model. Technology and Health Care, 29, 351-358. [Google Scholar] [CrossRef
[8] Wang, X., Ren, H. and Zhan, Y. (2017) Characterization of Microbial Community Composition and Pathogens Risk Assessment in Typical Italian-Style Salami by High-Throughput Sequencing Technology. Food Science and Biotechnology, 27, 241-249. [Google Scholar] [CrossRef] [PubMed]
[9] Shen, L., Niu, J., Wang, C., et al. (2019) High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. Journal of Virology, 93, e00023-19. [Google Scholar] [CrossRef
[10] Sun, J., Chen, G., Jing, Y., He, X., et al. (2018) LncRNA Expression Profile of Human Thoracic Aortic Dissection by High-Throughput Sequencing. Cellular Physiology and Biochemistry, 46, 1027-1041. [Google Scholar] [CrossRef] [PubMed]
[11] Yang, F., Chen, Y., Xue, Z.Q., Lv, Y.G., Shen, L., et al. (2020) High-Throughput Sequencing and Exploration of the lncRNA-circRNA-miRNA-mRNA Network in Type 2 Diabetes Mellitus. BioMed Research International, 2020, Article ID: 8162524. [Google Scholar] [CrossRef] [PubMed]
[12] Liao, J., Wang, J., Liu, Y., Li, J. and Duan, L. (2019) Transcriptome Sequencing of lncRNA, miRNA, mRNA and Interaction Network Constructing in Coronary Heart Disease. BMC Medi-cal Genomics, 12, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, Y., Bai, L., Shi, M., et al. (2017) Features and Risk Fac-tors of Carotid Atherosclerosis in a Population with High Stroke Incidence in China. Oncotarget, 8, 57477-57488. [Google Scholar] [CrossRef] [PubMed]
[14] Bian, L., Xia, L., Wang, Y., et al. (2018) Risk Factors of Subclini-cal Atherosclerosis and Plaque Burden in High Risk Individuals: Results from a Community-Based Study. Frontiers in Physiology, 9, Article No. 739. [Google Scholar] [CrossRef] [PubMed]
[15] Jayachandran, M. and Qu, S. (2021) Harnessing Hyperuricemia to Atherosclerosis and Understanding Its Mechanistic Dependence. Medicinal Research Reviews, 41, 616-629. [Google Scholar] [CrossRef] [PubMed]
[16] Bai, Y., Zhang, Q., Su, Y., Pu, Z. and Li, K. (2019) Modulation of the Proliferation/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a/Smad1 Axis. International Heart Journal, 60, 444-450. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, Y.Q., Xu, Z.M., Wang, X.L., et al. (2020) LncRNA FOXC2-AS1 Regulated Proliferation and Apoptosis of Vascular Smooth Muscle Cell through Targeting miR-1253/FOXF1 Axis in Atherosclerosis. European Review for Medical and Pharmacological Sciences, 24, 3302-3314.
[18] Huang, S.F., Zhao, G., Peng, X.F. and Ye, W.C. (2021) The Patho-genic Role of Long Non-Coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway. Frontiers in Cardiovascular Medicine, 8, Article ID: 770163. [Google Scholar] [CrossRef] [PubMed]
[19] Liu, L., Tan, L., Yao, J. and Yang, L. (2020) Long Non-Coding RNA MALAT1 Regulates Cholesterol Accumulation in ox-LDL-Induced Macrophages via the mi-croRNA-17-5p/ABCA1 Axis. Molecular Medicine Reports, 21, 1761-1770. [Google Scholar] [CrossRef] [PubMed]
[20] Wei, J., Zeng, Y., Gao, X. and Liu, T. (2021) A Novel Ferropto-sis-Related lncRNA Signature for Prognosis Prediction in Gastric Cancer. BMC Cancer, 21, Article No. 1221. [Google Scholar] [CrossRef] [PubMed]
[21] Jiang, Y., Chen, J., Ling, J., et al. (2021) Construction of a Gly-colysis-Related Long Noncoding RNA Signature for Predicting Survival in Endometrial Cancer. Journal of Cancer, 12, 1431-1444. [Google Scholar] [CrossRef] [PubMed]
[22] Guo, J.N., Xia, T.Y., Deng, S.H., Xue, W.N., Cui, B.B. and Liu, Y.L. (2021) Prognostic Immunity and Therapeutic Sensitivity Analyses Based on Differential Genomic Instabil-ity-Associated LncRNAs in Left- and Right-Sided Colon Adenocarcinoma. Frontiers in Molecular Biosciences, 8, Arti-cle ID: 668888. [Google Scholar] [CrossRef] [PubMed]
[23] Liu, H. and Cheng, Y. (2022) Identification of Autophagy-Related Long Non-Coding RNAs in Endometrial Cancer via Comprehensive Bioinformatics Analysis. BMC Women’s Health, 22, Article No. 85. [Google Scholar] [CrossRef] [PubMed]
[24] Xia, F., Yan, Y. and Shen, C. (2021) A Prognostic Pyropto-sis-Related lncRNAs Risk Model Correlates with the Immune Microenvironment in Colon Adenocarcinoma. Frontiers in Cell and Developmental Biology, 9, Article ID: 811734. [Google Scholar] [CrossRef] [PubMed]
[25] Ai, L.Y., Du, M.Z., Chen, Y.R., Xia, P.Y., Zhang, J.Y. and Jiang, D. (2022) Integrated Analysis of lncRNA and mRNA Expression Profiles Indicates Age-Related Changes in Meniscus. Frontiers in Cell and Developmental Biology, 10, Article ID: 844555. [Google Scholar] [CrossRef] [PubMed]
[26] Suzuki, M., Tomoike, H., Sumiyoshi, T., et al. (2017) Incidence of Cancers in Patients with Atherosclerotic Cardiovascular Diseases. International Journal of Cardiology: Heart & Vascu-lature, 17, 11-16. [Google Scholar] [CrossRef] [PubMed]
[27] DiRenzo, D., Owens, G.K. and Leeper, N.J. (2017) “Attack of the Clones”: Commonalities between Cancer and Atherosclerosis. Circulation Research, 120, 624-626. [Google Scholar] [CrossRef
[28] Wang, S.C., Schulman-Marcus, J., Fantauzzi, J., et al. (2019) Colon Cancer Laterality Is Associated with Atherosclerosis and Coronary Artery Disease. Journal of Gastroin-testinal Oncology, 10, 30-36. [Google Scholar] [CrossRef] [PubMed]